1,368 Shares in Axon Enterprise, Inc. (NASDAQ:AXON) Bought by IronOak Wealth LLC.

IronOak Wealth LLC. bought a new stake in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 1,368 shares of the biotechnology company's stock, valued at approximately $813,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of AXON. Mutual Advisors LLC bought a new stake in shares of Axon Enterprise during the fourth quarter valued at approximately $333,000. Brighton Jones LLC bought a new stake in shares of Axon Enterprise during the fourth quarter valued at approximately $480,000. Geneos Wealth Management Inc. raised its holdings in shares of Axon Enterprise by 630.0% during the fourth quarter. Geneos Wealth Management Inc. now owns 1,847 shares of the biotechnology company's stock valued at $1,098,000 after buying an additional 1,594 shares during the last quarter. Kingswood Wealth Advisors LLC bought a new stake in shares of Axon Enterprise during the fourth quarter valued at approximately $525,000. Finally, Blue Trust Inc. raised its holdings in shares of Axon Enterprise by 70.4% during the fourth quarter. Blue Trust Inc. now owns 496 shares of the biotechnology company's stock valued at $295,000 after buying an additional 205 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several brokerages recently commented on AXON. JMP Securities reissued an "outperform" rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Needham & Company LLC boosted their target price on Axon Enterprise from $600.00 to $750.00 and gave the stock a "buy" rating in a report on Thursday, May 8th. Craig Hallum cut Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. Northcoast Research cut Axon Enterprise from a "buy" rating to a "neutral" rating in a report on Wednesday, February 19th. Finally, The Goldman Sachs Group boosted their target price on Axon Enterprise from $730.00 to $830.00 and gave the stock a "buy" rating in a report on Wednesday, May 14th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and ten have given a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $652.73.

Insider Activity

In other news, President Joshua Isner sold 9,905 shares of the business's stock in a transaction on Wednesday, May 21st. The shares were sold at an average price of $738.03, for a total transaction of $7,310,187.15. Following the transaction, the president now directly owns 298,809 shares in the company, valued at $220,530,006.27. The trade was a 3.21% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Jeri Williams sold 307 shares of the business's stock in a transaction on Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the transaction, the director now owns 1,627 shares in the company, valued at approximately $899,275.44. This represents a 15.87% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 34,969 shares of company stock worth $23,127,314 in the last ninety days. Corporate insiders own 5.70% of the company's stock.

Axon Enterprise Price Performance

Axon Enterprise stock traded up $13.34 during mid-day trading on Friday, hitting $743.63. The company's stock had a trading volume of 1,121,061 shares, compared to its average volume of 732,673. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $57.89 billion, a P/E ratio of 192.15, a P/E/G ratio of 5.17 and a beta of 1.24. Axon Enterprise, Inc. has a twelve month low of $273.52 and a twelve month high of $755.05. The stock's fifty day moving average price is $620.57 and its two-hundred day moving average price is $610.50.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, topping the consensus estimate of $1.34 by $0.07. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. The firm had revenue of $603.63 million for the quarter, compared to analysts' expectations of $585.67 million. During the same period in the previous year, the company posted $1.15 EPS. The company's quarterly revenue was up 31.3% compared to the same quarter last year. Research analysts forecast that Axon Enterprise, Inc. will post 5.8 earnings per share for the current year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.